Business Description
IDEAYA Biosciences is a cancer drug company based in South San Francisco that focuses on matching treatments to patients based on their specific genetic profiles. The company has built a broad pipeline of experimental drugs targeting a range of cancer types, including uveal melanoma, small cell lung cancer, and tumors driven by particular genetic mutations, with several candidates already in clinical trials. IDEAYA also uses advanced screening tools and machine-learning technology to identify new drug targets and strengthen its discovery efforts. The company works alongside major pharmaceutical partners including GlaxoSmithKline, Pfizer, Gilead Sciences, and Novartis, and has been operating since 2015.
